services include design and execution of minimally invasive neurointerventional procedures under MRI and CT guidance, as well as behavioral testing, telemetry, histology, and flow cytometry readouts. Ti-com provides platforms for targeted delivery and biodistribution studies of therapeutic agents and hydrogels using intra-arterial and other administration routes. It works with biotechnology companies, medical device developers, and academic institutions seeking clinically relevant translational data to support precision medicine approaches in neurology and neuro-oncology. Through project planning, regulatory support, and comprehensive data collection, Ti-com supports the progression of experimental therapies toward clinical application.